Patent strategy in pharmaceutical industry : are additional patents valuable?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783848709915
3848709910
- Maße
-
23 cm
- Umfang
-
84 S.
- Ausgabe
-
1. Aufl.
- Sprache
-
Englisch
- Anmerkungen
-
graph. Darst.
Zugl.: München, Munich Intellectuel Property Law Center, Masterarbeit, 2012
- Erschienen in
-
MIPLC studies / Munich Intellectual Property Law Center ; Vol. 20
- Klassifikation
-
Recht
- Ereignis
-
Veröffentlichung
- (wo)
-
Baden-Baden
- (wer)
-
Nomos
- (wann)
-
2014
- Urheber
-
Donghi, Monica
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:18 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Donghi, Monica
- Nomos
Entstanden
- 2014
Ähnliche Objekte (12)
Evaluating the US pharmaceutical patent policy
Second generation patents in pharmaceutical innovation
The right to health in pharmaceutical patent disputes
Pharmaceutical patents: incentives for R&D or marketing?
Optimal incentives for patent challenges in the pharmaceutical industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Law and Economics of Patent Settlements in the Pharmaceutical Industry
Implementing pro-competitive criteria for the examination of pharmaceutical patents
Law and economics of patent settlements in the pharmaceutical industry
Evaluating the US pharmaceutical patent policy
Second generation patents in pharmaceutical innovation
The right to health in pharmaceutical patent disputes
Pharmaceutical patents: incentives for R&D or marketing?
Optimal incentives for patent challenges in the pharmaceutical industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Law and Economics of Patent Settlements in the Pharmaceutical Industry
Implementing pro-competitive criteria for the examination of pharmaceutical patents
Law and economics of patent settlements in the pharmaceutical industry
Evaluating the US pharmaceutical patent policy
Second generation patents in pharmaceutical innovation
The right to health in pharmaceutical patent disputes
Pharmaceutical patents: incentives for R&D or marketing?
Optimal incentives for patent challenges in the pharmaceutical industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Law and Economics of Patent Settlements in the Pharmaceutical Industry
Implementing pro-competitive criteria for the examination of pharmaceutical patents